Rilutek (riluzole) tablets, the first drug approved for amyotrophic lateral sclerosis
February 1996
Rhone-Poulenc Rorer is now marketing Rilutek (riluzole) tablets, the first drug approved for amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).
ALS is a progressive, degenerative disease of the nerves. It leads to muscle weakness...paralysis...and eventually death.
ALS is thought to be caused by excess glutamate...an excitatory neurotransmitter that causes nerve damage.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote